Benchling
We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific data and AI are built into how science gets done. Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.www.benchling.com
3
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 3 mentions across 2 episodes found for "Benchling".
Sep 1, 2026
Jackson DahlHOST
Myles is an investor and partner at Thrive Capital.
Jackson DahlHOST
He has spent most of his career there investing in mostly software companies, including Cursor, Chai Discovery, Turbo Puffer, Benchling, GitHub, and many more.
Jackson DahlHOST
Myles began his career at Thrive over a decade ago, but he also spent three years at another investment firm, Benchmark, before returning to Thrive in 2024.
Jackson DahlHOST
I only met Miles recently, but over the years I've heard about him as one of the most impressive, thoughtful, driven, competitive venture investors out there.
20 MINS LATER
Miles GrimshawGUEST
Because one of the things that we will do a heck of a lot of with any team is recruit for that company.
Miles GrimshawGUEST
And so whether it's in the investment conversation or just in my bones personally, I'm thinking about the pitch to the first recruit this year, tomorrow, and the recruit 10 years from now that one is doing.
Miles GrimshawGUEST
I'm still helping Sajia Benchling recruit and close talent or key people.
Miles GrimshawGUEST
And I think that through that journey of getting to know each other, a founder hopefully says, sure, I want to raise money from these people, but actually I kind of want them on their team.
Matt MurphyGUEST
But in our portfolio, I mean, we've seen companies that have embraced AI and have accelerated out of that and who have great businesses at scale, like, you know, a company like Carta that's over 500 million of ARR growing quickly.
Matt MurphyGUEST
Uh, you know, uh, you know, Benchling, which was the system of record and now has added in a bunch of AI model building and things like that.
Matt MurphyGUEST
But I can name 10 other companies that still haven't figured out that, you know, AI thing that's really going to help them take off.
Carl QuintanillaHOST
Finally, it's been suggested to us, uh, from some corporates that those companies that have used this year to really get aggressive in their spend, maybe too aggressive on cost, but they'll manage that, will start to roll out some metrics maybe in Q1, Q2 of next year, where they're starting to demonstrate ROI and how these u- these use cases can be put together at scale.